经尿道双极等离子前列腺腔内剜除术治疗前列腺增生220例临床疗效分析

Bipolar plasmakinetic transurethral enucleation of prostate in the treatment of benign prostatic hyperplasia:Report of 220 cases

目的观察前列腺增生腔内治疗方法——经尿道双极等离子前列腺腔内剜除法的临床疗效。方法对220例前列腺增生患者行经尿道双极等离子前列腺腔内剜除术,观察手术时间,术中出血量,术后留置导尿管时间,术后并发症,比较手术前后的国际前列腺症状评分(IPSS)、生活质量评分(QOL)、残余尿量(RU)、最大尿流率(Qmax)的差异。结果手术时间30～90min,平均40±10min;术中出血量70±10ml;术后留置导尿管时间4±0.5d;全部患者随访6～12个月,IPSS由27.8±2.3分下降9.6±2.6、QOL由5.5±0.5减少至1.5±0.5;剩余尿量由110±7ml下降到25±4ml;Qmax由8.0±2.3ml/s上升至18±2.4ml/s。所有病例随访6～12个月。结论经尿道双极等离子前列腺腔内剜除法切除组织彻底,出血少,并发症少,技术可行,疗效确定。

Objective To evaluate the clinical effect of transurethral resection of prostate with the bipolar plasmakinetic technique （PKRP） in the treatment of benign prostate hyperplasia （BPH）. Methods Two hundred and tuenty patients with BPH underwent transurethral enucleation of prostate with the bipolar plasmakinetic technique. The clinical parameters include operation time, blood loss, postoperative catheter retention time, postoperative complication rates, compare the differences of International Prostate Symptoms Score（IPSS）, Quality of life（QOL）, Residual urine （RU） and maximum urine flow rate（Qmax） pre-and postoperatively. Results Mean operation time was 40±10 min, range 30 to 90 min. Mean blood loss was 70±10 ml. Postoperative indwelling catheter time was 4±0.5 days. All cases were followed up for 6 to 12 months, IPSS by the 27.8±2.3 points down to 9.6±2.6, QOL by the 5.5±0.5 decreased to 1.5±0.5; residual urine from the 110±7 ml down to 25±4 ml; Qmax by the 8.0±2.3 ml/s up to 18±2.4 ml/s. Conclusions Transurethral enucleation of the prostate with the bipolar plasma kinetic technique has advantages of high safety, less complication and satisfactory efficacy and was a safe and effective measure for the treatment of BPH.